athenahealth, Inc. (NASDAQ:ATHN) Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $132.97, for a total value of $106,376.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Brandon H. Hull also recently made the following trade(s):

  • On Monday, November 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The stock was sold at an average price of $130.00, for a total value of $104,000.00.
  • On Friday, October 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The stock was sold at an average price of $130.00, for a total value of $104,000.00.

Shares of athenahealth, Inc. (NASDAQ:ATHN) opened at $134.51 on Tuesday. The firm has a market capitalization of $5,308.75, a price-to-earnings ratio of 112.42, a PEG ratio of 4.98 and a beta of 1.57. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.35. athenahealth, Inc. has a 1 year low of $90.11 and a 1 year high of $158.66.

athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.06. The firm had revenue of $304.60 million during the quarter, compared to the consensus estimate of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The company’s revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.60 EPS. sell-side analysts anticipate that athenahealth, Inc. will post 1.2 earnings per share for the current year.

A number of research analysts recently weighed in on the company. Oppenheimer reissued a “buy” rating and set a $184.00 target price on shares of athenahealth in a report on Friday, October 20th. Piper Jaffray Companies reissued a “buy” rating and set a $167.00 target price on shares of athenahealth in a report on Tuesday, October 17th. SunTrust Banks reissued a “buy” rating and set a $156.00 target price on shares of athenahealth in a report on Wednesday, October 25th. Robert W. Baird decreased their target price on athenahealth from $170.00 to $155.00 and set an “outperform” rating on the stock in a report on Sunday, October 22nd. Finally, Jefferies Group set a $110.00 target price on athenahealth and gave the stock a “hold” rating in a report on Friday, October 13th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eleven have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $143.22.

Several large investors have recently added to or reduced their stakes in ATHN. Turner Investments LLC bought a new stake in shares of athenahealth during the 2nd quarter valued at $105,000. Bessemer Group Inc. lifted its position in shares of athenahealth by 13.7% during the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after acquiring an additional 113 shares during the period. The Manufacturers Life Insurance Company lifted its position in shares of athenahealth by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after acquiring an additional 84 shares during the period. Seven Bridges Advisors LLC lifted its position in shares of athenahealth by 5.4% during the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after acquiring an additional 67 shares during the period. Finally, BNP Paribas Arbitrage SA lifted its position in shares of athenahealth by 123.8% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock valued at $189,000 after acquiring an additional 744 shares during the period.

TRADEMARK VIOLATION NOTICE: “athenahealth, Inc. (ATHN) Director Brandon H. Hull Sells 800 Shares of Stock” was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this piece can be read at https://theolympiareport.com/2017/12/05/athenahealth-inc-athn-director-brandon-h-hull-sells-800-shares-of-stock.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.